Avita Medical Inc.
NASDAQ: RCEL0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Cary G. Vance
- Employees
- 232
- Headquarters
- Valencia, United States
- IPO year
- 2012
- Market cap
- $98.1M
- Website
- https://avitamedical.com
Loading RCEL…
Loading profile data…Frequently asked questions about RCEL
What does Avita Medical Inc. (RCEL) do?
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company’s lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as wel...
Where does RCEL trade?
Avita Medical Inc. (RCEL) trades on the NASDAQ.
What sector is RCEL in?
Avita Medical Inc. (RCEL) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Avita Medical Inc.?
Cary G. Vance is the chief executive officer of Avita Medical Inc. (RCEL).
Where is Avita Medical Inc. headquartered?
Avita Medical Inc. is headquartered in United States.
Does RCEL pay a dividend?
Avita Medical Inc. (RCEL) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did RCEL go public?
Avita Medical Inc. (RCEL) completed its initial public offering in 2012.